Skip to main content

Advertisement

Log in

Genetic variations in transcription factor 7-like 2 (TCF7L2) gene: association of TCF7L2 rs12255372(G/T) or rs7903146(C/T) with breast cancer risk and clinico-pathological parameters

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The purpose of the present study was to evaluate the association between TCF7L2 rs12255372(G/T) or rs7903146(C/T) polymorphism and breast cancer risk, and clinico-pathologic characteristics of the patients. Genotyping of these polymorphisms was performed on 387 breast cancer patients and 252 normal and healthy women who had no history of any malignancy using polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) method in a hospital-based Malaysian population. The allele (P = 0.033) frequency of rs7903146 (T) polymorphism was significantly higher in the cancer patients than normal individuals. No significant association was demonstrated between CT (ORadj = 1.386; 95% CI, 0.985–1.949) or TT (ORadj = 1.579; 95% CI, 0.869–2.870) genotype and breast cancer risk. However, women who were carriers of T allele (ORadj = 1.316; 95% CI, 1.022–1.695) or T allele genotype (ORadj = 1.419; 95% CI, 1.027–1.960) showed significant increased risk of breast cancer. Women who were GT heterozygotes (ORadj = 1.329; 95% CI, 0.948–1.862) or TT homozygotes (ORadj = 1.574; 95% CI, 0.829–2.987), and carriers of T allele genotype (ORadj = 1.365; 95% CI, 0.989–1.883) or T allele (ORadj = 1.284; 95% CI, 0.995–1.657) were not associated with breast cancer risk. The rs7903146(T) allele genotype was significantly associated with nodal involvement (P = 0.003) but rs12255372 (T) allele genotype was not associated with the clinico-pathologic characteristics. In conclusion, our findings suggest that rs7903146 (T) variant may elevate the risk of breast cancer, thus could be a potential candidate for breast cancer susceptibility. The variant may also increase the metastatic potential of the tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science. 2004;303:1483–7.

    Article  PubMed  CAS  Google Scholar 

  2. Prunier C, Hocevar BA, Howe PH. Wnt signaling: physiology and pathology. Growth Factors. 2004;22:141–50.

    Article  PubMed  CAS  Google Scholar 

  3. Sjoblom T, et al. The consensus coding sequences of human breast and colorectal cancers. Science. 2006;314:268–74.

    Article  PubMed  Google Scholar 

  4. Wong NA, Pignatelli M. Beta-catenin-a linchpin in colorectal carcinogenesis? Am J Pathol. 2002;160:389–401.

    Article  PubMed  CAS  Google Scholar 

  5. Bafico A, Liu G, Goldin L, Harris V, Aaronson SA. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 2004;6:497–506.

    Article  PubMed  CAS  Google Scholar 

  6. Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res. 2007;9:R63.

    Article  PubMed  Google Scholar 

  7. Lin SY, et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA. 2000;97:4262–6.

    Article  PubMed  CAS  Google Scholar 

  8. Ozaki S. Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer. Oncol Rep. 2005;14:1437–43.

    PubMed  CAS  Google Scholar 

  9. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422–6.

    Article  PubMed  CAS  Google Scholar 

  10. Barker N, Huls G, Korinek V, Clevers H. Restricted high level expression of TCF-4 protein in intestinal and mammary gland epithelium. Am J Pathol. 1999;154:29–35.

    Article  PubMed  CAS  Google Scholar 

  11. Duval A, et al. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res. 2000;60:3872–9.

    PubMed  CAS  Google Scholar 

  12. Sun P, Xiong H, Kim TH, Ren B, Zhang Z. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells. Mol Pharmacol. 2006;69:520–31.

    Article  PubMed  CAS  Google Scholar 

  13. Li CY, Wang Y, Cui ZS, Wang EH. Expression of T cell factor-4 in non-small-cell lung cancer. Chin Med J (Engl). 2005;118:136–40.

    Article  CAS  Google Scholar 

  14. Grant SF. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38:320–3.

    Article  PubMed  CAS  Google Scholar 

  15. Sladek R. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881–5.

    Article  PubMed  CAS  Google Scholar 

  16. Cauchi S, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. Mol Med. 2007;85:777–82.

    Article  CAS  Google Scholar 

  17. Bodhini D, Radha V, Dhar M, Narayani N, Mohan V. The rs12255372(G/T) and rs7903146(C/T) polymorphisms of the TCF7L2 gene are associated with type 2 diabetes mellitus in Asian Indians. Metabolism. 2007;56:1174–8.

    Article  PubMed  CAS  Google Scholar 

  18. Burwinkel B, et al. Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study. BMC Cancer. 2006;6:268.

    Article  PubMed  Google Scholar 

  19. Agalliu I, et al. Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study. Prostate. 2008;68:740–7.

    Article  PubMed  Google Scholar 

  20. Folsom AR, et al. Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2008;31:905–9.

    Article  PubMed  Google Scholar 

  21. Slattery ML, et al. Transcription factor 7-like 2 polymorphism and colon cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:978–82.

    Article  PubMed  CAS  Google Scholar 

  22. Goode EL, et al. No association between TCF7L2 variant and risk of breast or ovarian cancer. BMC Cancer. 2009;9:312–5.

    Article  PubMed  Google Scholar 

  23. Hazra A, Fuchs CS, Chan AT, Giovannucci EL, Hunter DJ. Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk. Cancer Causes Control. 2008;19:975–80.

    Article  PubMed  Google Scholar 

  24. Shtutman M, et al. The cyclin D1 gene is a target of the betacatenin/LEF-1 pathway. Proc Natl Acad Sci USA. 1999;96:5522–7.

    Article  PubMed  CAS  Google Scholar 

  25. Lim GCC, Halimah Y. Second report of the national cancer registry. Cancer incidence in Malaysia 2003. Kuala Lumpur: National cancer registry; 2004.

    Google Scholar 

  26. Naidu R, Har YC, Taib NA. Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development. Oncol Res. 2009;18(2–3):65–71.

    Article  PubMed  CAS  Google Scholar 

  27. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer I. Histopathology. 1991;19:403–10.

    Article  PubMed  CAS  Google Scholar 

  28. Bloom HIG, Richardson WW. Histological grading and prognosis. Br J Cancer. 1957;11:359–77.

    Article  PubMed  CAS  Google Scholar 

  29. Breast. AJCC cancer staging manual. In: American Joint Committee on Cancer, 6th editor. New York: Springer; 2002. p. 171–180.

  30. Singletary E, et al. Revision of the American Joint committee on cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628–36.

    Article  PubMed  Google Scholar 

  31. Naidu R, Har YC, Taib NA. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer. J Exp Clin Cancer Res. 2007;26:133–40.

    PubMed  CAS  Google Scholar 

  32. Tsao DA, et al. Single nucleotide polymorphism of TCF7L2 and Adiponectin genes for type 2 diabetes mellitus in Taiwan. Fooyin J Health Sci. 2009;1:41–7.

    Article  CAS  Google Scholar 

  33. Habalova V, Klimcakova L, Zidzik J, Tkac I. Rapid cost effective genotyping method for polymorphisms in PPARG, PPARGC1 and TCF7L2 genes. Mol Cell Probes. 2009;23:52–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was financially supported by E-ScienceFund grant (02-02-10-SF0016) from Ministry of Science, Technology and Innovation, Malaysia.

Conflict of interest

The authors declare that they have no conflict of interest related to the publication of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Naidu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naidu, R., Yip, C.H. & Taib, N.A.M. Genetic variations in transcription factor 7-like 2 (TCF7L2) gene: association of TCF7L2 rs12255372(G/T) or rs7903146(C/T) with breast cancer risk and clinico-pathological parameters. Med Oncol 29, 411–417 (2012). https://doi.org/10.1007/s12032-011-9837-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-011-9837-8

Keywords

Navigation